The Independent Voice of
European Private Equity

Advanced Search

Stanley Capital’s LXO acquires Nimotop from Bayer

Xhulio Ismalaj 6 November 2023

Stanley Capital Partners’ portfolio company Laboratoire X.O (LXO) has acquired Nimotop from Bayer for several global markets, excluding mainland China.

Next article »

« Previous article

Related Articles

Profile: Fondo Italiano d’Investimento celebrates raise of €1.2bn despite headwinds

08/05/24

Naxicap Partners acquires majority stake in spare parts distributor ITAL Express

08/05/24

Patrimonium and Wille Finance invest in EM

08/05/24

Montagu-backed HTL Biotechnology carves out Modern Meadow biomedical division

08/05/24

Squire Patton Boggs hires leveraged finance partner

08/05/24

Livonia Partners invests in Baltic tech firm Telema

08/05/24